Improvement_of_spontaneous_pregnancy_rate_after_stopping_gonadotropin_therapy_for_anovulatory_infertility._In_a_prospective_study,_140_patients_with_infertility_because_of_ovulatory_factors_(group_A)_were_followed_up_for_6_months_after_failure_to_achieve_pregnancy_using_human_menopausal_gonadotropin_(hMG)_therapy._They_included_cases_of_oligomenorrhea,_polycystic_ovarian_disease_(PCOD),_and_hypogonadotropic_amenorrhea._They_were_treated_with_hMG_alone_or_in_combination_with_clomiphene_citrate_or_gonadotropin-releasing_hormone_agonist_analog._The_control_group_(B)_included_83_infertile_patients_because_of_similar_ovulatory_factors._They_were_followed_up_for_6_months_not_preceded_by_ovulation_induction._The_overall_pregnancy_rate_(PR)_in_group_A_(20.7%)_was_significantly_higher_than_group_B_(7.2%)._The_PR_was_significantly_higher_in_oligomenorrhea_and_PCOD_patients_when_compared_with_the_control_group._There_was_no_significant_difference_in_the_hypogonadotropic_group.